EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Clozapine prescribing in treatment-resistant schizophrenia – an updated systematic literature review of barriers and facilitators among clinicians

Siobhán Nolan, Laura J Sahm, Ita Fitzgerald

European Journal of Clinical Pharmacology · 2026-05 · 82 (5)

DOI: 10.1007/s00228-026-04046-2 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift European Journal of Clinical Pharmacology, online erschienen am 11.04.2026. Verfasst von Siobhán Nolan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, Cork, Ireland. Hauptthemen laut MEDLINE: Clozapine, Antipsychotic Agents, Practice Patterns, Physicians', Schizophrenia, Treatment-Resistant. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University College Cork.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Increased rates of clozapine prescribing are essential to improving timely patient access within treatment-resistant schizophrenia (TRS) management. The extent of geographical variation in its use suggests it is possible to develop interventions to increase clinician engagement. To inform intervention development, a contemporary review of barriers and facilitators to increased clozapine prescribing is required. We aimed to conduct a systematic review of research addressing barriers and facilitators to clozapine prescribing among clinicians within TRS management.

Methods

The review was conducted in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. PubMed, Embase, CINAHL, and PsycINFO were searched from inception to July 2025. Results were synthesized qualitatively.

Results

Fifteen studies were included. Barriers related to clinicians, patients and carers, and healthcare institutions. Primary clinician-related barriers included insufficient knowledge of, and confidence in, managing clozapine treatment and the associated administrative burden. Primary patient-related barriers included concerns regarding patients’ willingness to consistently adhere to clozapine treatment and associated monitoring requirements. A lack of dedicated systems of care to facilitate clozapine initiation and shared community care were the leading institutional barriers. Major facilitators included improved education for clinicians, access to point-of-care testing, and increased availability of dedicated clozapine clinics.

Conclusion

Most barriers to systematically increasing clozapine prescribing rates are beyond the influence of individual prescribers. Instead, structural interventions focusing on (i) reducing the administrative burden associated with establishing clozapine treatment, (ii) increasing access to standardised training and supervision opportunities, and (iii) providing longitudinal support to clinicians when managing clozapine treatment, are required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClozapineAntipsychotic AgentsPractice Patterns, Physicians'Schizophrenia, Treatment-ResistantSchizophreniaHumans

Stichwörter der Autor:innen

BarriersClozapineFacilitatorsPrescribingSchizophreniaSystematic review

Substanzen

ClozapineAntipsychotic Agents

Autor:innen und Institutionen

  • Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, Cork, Ireland.
  • Pharmacy Department, St Patrick's Mental Health Services, Dublin, Ireland.
  • Pharmaceutical Care Research Group, School of Pharmacy, University College Cork, Cork, Ireland. ita.fitzgerald@ucc.ie.
  • Pharmacy Department, St Patrick's Mental Health Services, Dublin, Ireland. ita.fitzgerald@ucc.ie.
  • School of Pharmacy, College of Health and Life Sciences, Aston University, Birmingham, UK. ita.fitzgerald@ucc.ie.

Förderung

  • University College Cork

Zitieren

APA

Nolan, S., Sahm, L. J., & Fitzgerald, I. (2026). Clozapine prescribing in treatment-resistant schizophrenia – an updated systematic literature review of barriers and facilitators among clinicians. European Journal of Clinical Pharmacology, 82(5). https://doi.org/10.1007/s00228-026-04046-2

Vancouver

Nolan S, Sahm LJ, Fitzgerald I. Clozapine prescribing in treatment-resistant schizophrenia – an updated systematic literature review of barriers and facilitators among clinicians. European Journal of Clinical Pharmacology. 2026;82(5). doi:10.1007/s00228-026-04046-2

BibTeX
@article{Nolan2026,
  author = {Nolan, Siobhán and Sahm, Laura J and Fitzgerald, Ita},
  title = {Clozapine prescribing in treatment-resistant schizophrenia – an updated systematic literature review of barriers and facilitators among clinicians},
  journal = {European Journal of Clinical Pharmacology},
  year = {2026},
  volume = {82},
  number = {5},
  doi = {10.1007/s00228-026-04046-2}
}
Kostenlos starten →